Literature DB >> 12087128

Role of the short isoform of myosin light chain kinase in the contraction of cultured smooth muscle cells as examined by its down-regulation.

Jianjun Bao1, Kazuhiko Oishi, Tomohisa Yamada, Liqun Liu, Akio Nakamura, Masaatsu K Uchida, Kazuhiro Kohama.   

Abstract

GbaSM-4 cells, smooth muscle cells derived from brain basilar artery, which express both 210-kDa long and 130-kDa short isoforms of myosin light chain kinase (MLCK), were infected with an adenovirus vector carrying a 1.4-kb catalytic portion of MLCK-cDNA in an antisense orientation. Western blot analysis showed that the expression of short MLCK was depressed without affecting long MLCK expression. The contraction of the down-regulated cells was measured by the cell-populated collagen-fiber method. The tension development after stimulation with norepinephrine or was depressed. The additional infection of the down-regulated cells with the adenovirus construct containing the same insert in a sense direction rescued not only the short MLCK expression but also contraction, confirming the physiological role of short MLCK in the contraction. To examine the role of long MLCK in the residual contraction persisting in the short MLCK-deficient cells, long MLCK was further down-regulated by increasing the multiplicity of infection of the antisense construct. The additional down-regulation of long MLCK expression, however, did not alter the residual contraction, ruling out the involvement of long MLCK in the contractile activity. Further, in the cells where short MLCK was down-regulated specifically, the extent of phosphorylation of 20-kDa myosin light chain (MLC20) after the agonist stimulation was not affected. This finding suggests that there are additional factors to MLC20 phosphorylation that contribute to regulate smooth muscle contraction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087128      PMCID: PMC123179          DOI: 10.1073/pnas.142298599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis.

Authors:  M Ito; V Guerriero; X M Chen; D J Hartshorne
Journal:  Biochemistry       Date:  1991-04-09       Impact factor: 3.162

2.  Molecular characterization of a mammalian smooth muscle myosin light chain kinase.

Authors:  P J Gallagher; B P Herring; S A Griffin; J T Stull
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

3.  Oxytocin contracts rat uterine smooth muscle in Ca2(+)-free medium without any phosphorylation of myosin light chain.

Authors:  K Oishi; H Takano-Ohmuro; N Minakawa-Matsuo; O Suga; H Karibe; K Kohama; M K Uchida
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

4.  Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation.

Authors:  Y Kureishi; S Kobayashi; M Amano; K Kimura; H Kanaide; T Nakano; K Kaibuchi; M Ito
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

5.  Regulatory and structural motifs of chicken gizzard myosin light chain kinase.

Authors:  N J Olson; R B Pearson; D S Needleman; M Y Hurwitz; B E Kemp; A R Means
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Stimulation of the ATP-dependent interaction between actin and myosin by a myosin-binding fragment of smooth muscle caldesmon.

Authors:  Y Lin; R Ishikawa; T Okagaki; L H Ye; K Kohama
Journal:  Cell Motil Cytoskeleton       Date:  1994

7.  Myosin light chain kinase in endothelium: molecular cloning and regulation.

Authors:  J G Garcia; V Lazar; L I Gilbert-McClain; P J Gallagher; A D Verin
Journal:  Am J Respir Cell Mol Biol       Date:  1997-05       Impact factor: 6.914

8.  The structure and function of the actin-binding domain of myosin light chain kinase of smooth muscle.

Authors:  L H Ye; K Hayakawa; H Kishi; M Imamura; A Nakamura; T Okagaki; T Takagi; A Iwata; T Tanaka; K Kohama
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

9.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.

Authors:  M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

10.  Dynamics of myosin light chain phosphorylation at Ser19 and Thr18/Ser19 in smooth muscle cells in culture.

Authors:  K Sakurada; M Seto; Y Sasaki
Journal:  Am J Physiol       Date:  1998-06
View more
  5 in total

1.  Transforming growth factor-beta induces airway smooth muscle hypertrophy.

Authors:  Adam M Goldsmith; J Kelley Bentley; Limei Zhou; Yue Jia; Khalil N Bitar; Diane C Fingar; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-20       Impact factor: 6.914

2.  Ontogenesis of myosin light chain kinase mRNA and protein content in guinea pig tracheal smooth muscle.

Authors:  Pasquale Chitano; Judith A Voynow; Valeria Pozzato; Viviana Cantillana; Lauranell H Burch; Lu Wang; Thomas M Murphy
Journal:  Pediatr Pulmonol       Date:  2004-12

3.  Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.

Authors:  Huan Deng; Gregoriy A Dokshin; Jing Lei; Adam M Goldsmith; Khalil N Bitar; Diane C Fingar; Marc B Hershenson; J Kelley Bentley
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

4.  Reversible differentiation of immortalized human bladder smooth muscle cells accompanied by actin bundle reorganization.

Authors:  Naohiro Hashimoto; Tohru Kiyono; Fumihito Saitow; Minoru Asada; Masaki Yoshida
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

5.  Pennogenin tetraglycoside induces rat myometrial contraction and MLC20 phosphorylation via PLC-IP(3) and RhoA/Rho kinase signaling pathways.

Authors:  Limei Wang; Chao Jia; Zuyin Yu; Xiaolan Liu; Liping Kang; Yue Cong; Yajun Shan; Zhenhu Zhao; Baiping Ma; Yuwen Cong
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.